Normal levels of fibrinopeptide A in patients with primary hyperlipidemia

H. L. Nossel, F. R. Smith, A. H. Seplowitz, R. B. Dell, R. R. Sciacca, C. Merskey, D. S. Goodman

Producción científicarevisión exhaustiva

6 Citas (Scopus)

Resumen

Fibrinopeptide A (FPA) levels were measured in a group of 130 controls and patients with vrious types of primary hyperlipidemia to investigate whether an increased steady state level of thrombin activity is present in hyperlipidemic patients. In a subset of 56 subjects, levels of clotting factors II, VII, and X were measured as well. FPA levels in hyperlipidemic patients were not significantly different from those of control subjects. Furthermore, on multiple regression analysis, no significant relationships were found between FPA levels and the concentrations of serum cholesterol or triglyceride, or log triglyceride levels. Statistically significant relationships were found between all three clotting factors levels and triglyceride concentration. The correlation coefficients for these relationships, however, were low, so that the correlations are of questionable pathophysiological significance. A weak relationship also was found between the plasma levels of cholesterol and of factor II. Thus, although small increases in various clotting factors may be found in patients with hyperlipidemia, plasma FPA levels are normal. These data indicate that hyperlipidemia is not associated with a steady state of increased thrombin activity in vivo in humans.

Idioma originalEnglish
Páginas (desde-hasta)347-350
Número de páginas4
PublicaciónCirculation Research
Volumen45
N.º3
DOI
EstadoPublished - 1979

ASJC Scopus Subject Areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Huella

Profundice en los temas de investigación de 'Normal levels of fibrinopeptide A in patients with primary hyperlipidemia'. En conjunto forman una huella única.

Citar esto

Nossel, H. L., Smith, F. R., Seplowitz, A. H., Dell, R. B., Sciacca, R. R., Merskey, C., & Goodman, D. S. (1979). Normal levels of fibrinopeptide A in patients with primary hyperlipidemia. Circulation Research, 45(3), 347-350. https://doi.org/10.1161/01.RES.45.3.347